These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1683615)

  • 1. Beta-blockade in the primary prevention of coronary heart disease in hypertensive patients. Review of present evidence.
    Wikstrand J; Berglund G; Tuomilehto J
    Circulation; 1991 Dec; 84(6 Suppl):VI93-100. PubMed ID: 1683615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary prevention with beta-blockade in patients with hypertension: review of results and clinical implications.
    Wikstrand J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S64-75. PubMed ID: 11527139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Do beta-blockers prevent coronary events in hypertensive patients?].
    Diévart F; Ragot S; Julien J; Herpin D
    Arch Mal Coeur Vaiss; 2005 Sep; 98(9):881-8. PubMed ID: 16231574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of beta receptor blockade in preventing sudden death.
    Wikstrand J; Kendall M
    Eur Heart J; 1992 Sep; 13 Suppl D():111-20. PubMed ID: 1356781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers and primary cardioprotection in hypertension.
    Fogari R; Zoppi A
    Drugs Exp Clin Res; 1990; 16(3):113-22. PubMed ID: 1974838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking, antihypertensive treatment benefit, and comprehensive antihypertensive treatment approach: some thoughts on the results of the International Prospective Primary Prevention Study in Hypertension.
    Bolli P; Bühler FR; McKenzie JK
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S77-80. PubMed ID: 1708033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
    Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis. The INDANA Steering Committee.
    Lièvre M; Gueyffier F; Ekbom T; Fagard R; Cutler J; Schron E; Marre M; Boissel JP
    Diabetes Care; 2000 Apr; 23 Suppl 2():B65-71. PubMed ID: 10860193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of mortality and coronary prevention in hypertensive patients treated with beta-receptor blockers.
    Shinton RA; Beevers DG
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():31-4. PubMed ID: 1973461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of sudden death using beta-blockers. Review of possible contributory actions.
    Olsson G; Rydén L
    Circulation; 1991 Dec; 84(6 Suppl):VI33-7. PubMed ID: 1683608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of the primary prevention trials against coronary heart disease.
    Kannel WB
    J Hypertens Suppl; 1990 Dec; 8(7):S245-50. PubMed ID: 1982770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta blockade and intermittent claudication.
    Lepäntalo M
    Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of beta-blockers in the prevention of sudden cardiac death (SCD) in patients with coronary heart disease (CHD).
    Lamaida N; Capuano V; Di Mauro G; Aucello G; Scotto Di Quacquaro G
    Panminerva Med; 1994 Jun; 36(2):71-5. PubMed ID: 7831062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery disease can be prevented by antihypertensive therapy: experiences from the MAPHY Study.
    Tuomilehto J; Wikstrand J; Warnold I; Olsson G; Elmfeldt D; Berglund G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S75-6. PubMed ID: 1708032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
    Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
    Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.